Fiorino G - Search Results

1

Adalimumab in Crohn's disease: tips and tricks after 5 years of clinical experience.

Fiorino G, Szabò H, Fries W, Malesci A, Peyrin-Biroulet L, Danese S. Fiorino G, et al. Curr Med Chem. 2011;18(8):1230-8. doi: 10.2174/092986711795029726. Curr Med Chem. 2011. PMID: 21291363 Review.

2

Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases.

Szabò H, Fiorino G, Spinelli A, Rovida S, Repici A, Malesci AC, Danese S. Szabò H, et al. Among authors: fiorino g. Aliment Pharmacol Ther. 2010 Jan 15;31(2):189-201. doi: 10.1111/j.1365-2036.2009.04171.x. Epub 2009 Oct 13. Aliment Pharmacol Ther. 2010. PMID: 19832726 Review.

3

New drug delivery systems in inflammatory bowel disease: MMX and tailored delivery to the gut.

Fiorino G, Fries W, De La Rue SA, Malesci AC, Repici A, Danese S. Fiorino G, et al. Curr Med Chem. 2010;17(17):1851-7. doi: 10.2174/092986710791111170. Curr Med Chem. 2010. PMID: 20353384 Review.

4

Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy.

Danese S, Fiorino G, Reinisch W. Danese S, et al. Among authors: fiorino g. Aliment Pharmacol Ther. 2011 Jul;34(1):1-10. doi: 10.1111/j.1365-2036.2011.04679.x. Epub 2011 May 3. Aliment Pharmacol Ther. 2011. PMID: 21539588 Review.

5

Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease.

Fiorino G, Allez M, Malesci A, Danese S. Fiorino G, et al. Aliment Pharmacol Ther. 2009 May 1;29(9):921-7. doi: 10.1111/j.1365-2036.2009.03955.x. Epub 2009 Feb 10. Aliment Pharmacol Ther. 2009. PMID: 19210297 Review.

6

Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease.

Fiorino G, Bonifacio C, Peyrin-Biroulet L, Minuti F, Repici A, Spinelli A, Fries W, Balzarini L, Montorsi M, Malesci A, Danese S. Fiorino G, et al. Inflamm Bowel Dis. 2011 May;17(5):1073-80. doi: 10.1002/ibd.21533. Epub 2010 Nov 8. Inflamm Bowel Dis. 2011. PMID: 21484958 Clinical Trial.

7

Commentary: anaemia in inflammatory bowel disease--the most common and ignored extra intestinal manifestation.

Fiorino G, Allocca M, Danese S. Fiorino G, et al. Aliment Pharmacol Ther. 2014 Jan;39(2):227-8. doi: 10.1111/apt.12578. Aliment Pharmacol Ther. 2014. PMID: 24330239 No abstract available.

8

Commentary: Adjunct antibiotic combination therapy for ulcerative colitis--is it time to investigate Fusobacterium varium?

Fiorino G, Danese S. Fiorino G, et al. Aliment Pharmacol Ther. 2014 Jun;39(11):1333. doi: 10.1111/apt.12742. Aliment Pharmacol Ther. 2014. PMID: 24803247 No abstract available.

9

Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease.

Moja L, Danese S, Fiorino G, Del Giovane C, Bonovas S. Moja L, et al. Among authors: fiorino g. Aliment Pharmacol Ther. 2015 Jun;41(11):1055-65. doi: 10.1111/apt.13190. Epub 2015 Apr 13. Aliment Pharmacol Ther. 2015. PMID: 25864873 Review.

10

Golimumab: clinical update on its use for ulcerative colitis.

Gilardi D, Fiorino G, Allocca M, Bravatà I, Danese S. Gilardi D, et al. Among authors: fiorino g. Drugs Today (Barc). 2015 Mar;51(3):171-84. doi: 10.1358/dot.2015.51.3.2298240. Drugs Today (Barc). 2015. PMID: 25876561 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters